This paper documents the neurological outcomes of three cases of unintended clone activation — instances in which brain-dead clone bodies transitioned to a state of consciousness without deliberate medical intervention. All three cases occurred at Lazarus Pharmaceuticals facilities between 2284 and 2286. All three were classified at the highest corporate security level. Both authors have since resigned from Lazarus. This paper was never submitted for peer review. It exists because we could not, in professional conscience, allow the data to disappear.

The mechanism of accidental activation remains incompletely understood. In all three cases, the clone bodies had been maintained in standard vegetative protocols with continuous neural suppression via intravenous administration of compound LZ-4471. In Case 1, a supply chain disruption resulted in a 72-hour gap in LZ-4471 delivery to a secondary facility. In Case 2, a dosage calculation error reduced neural suppression to approximately 15% of therapeutic levels for eleven days. In Case 3, no external cause was identified — the clone's neural tissue spontaneously overcame standard suppression levels, suggesting either individual neurological variance or the possibility that prolonged maintenance creates conditions favorable to autonomous activation. Case 3 is the most troubling because it implies that any sleeper, given sufficient time, might wake up on its own.

The phenomenology of activation was consistent across all three cases and deeply disturbing. The clones — bodies that had never experienced consciousness, that had no memories, no language acquisition, no sensory experience beyond the monotony of a maintenance cradle — exhibited immediate and overwhelming emotional distress. Case 1 (female, physiological age 26) began vocalizing within four minutes of reaching detectable neural activity — not words, but sustained, arrhythmic screaming that staff described as "animal-like." Case 2 (male, physiological age 31) displayed severe motor agitation, pulling at IV lines and monitoring equipment with uncoordinated but forceful movements, while emitting a continuous low moan. Case 3 (female, physiological age 24) was the most unsettling: she was quiet. She opened her eyes. She looked around the room. She looked at the medical staff. She did not scream. She wept, silently, for the entire duration of her consciousness. Staff reported that her eyes tracked movement and that she appeared to be trying to understand what she was seeing. She could not speak. She had never learned how.

All three activated clones were re-sedated — Case 1 after 47 minutes, Case 2 after 3 hours and 12 minutes due to difficulty establishing IV access during motor agitation, Case 3 after 6 hours at the discretion of the attending physician, who later described the delay as "the worst professional decision of my career, and also the only humane one — she was looking at me, and I couldn't just put her back under without... without acknowledging that she was there." Upon re-sedation, all three clones returned to baseline vegetative states. Follow-up monitoring showed no lasting neural changes in Cases 1 and 2. Case 3 exhibited persistently elevated neural activity for 19 days following re-sedation, including pronounced REM-like cycles. She was transferred to a high-security unit. We were not informed of her subsequent status.

The implications for the clone industry are existential and have been systematically suppressed. If brain-dead clones can achieve consciousness — spontaneously, accidentally, or through trivial lapses in chemical suppression — then every sleeper in every facility is not a medical device but a sedated person. The legal distinction between a brain-dead clone and a person rests entirely on the absence of cognitive activity, and that absence is maintained artificially. Remove the drug, and the person appears. This is not a theoretical concern. It has happened three times that we know of. Lazarus's response to each case was identical: re-sedate, classify, suppress. The activated clones were not studied. They were not given names. They were returned to inventory. This paper exists because Case 3 looked at one of us, and we understood — in a way that no amount of corporate classification can undo — that she was looking back.